Agents of Impact Call No. 10: Calling trends and scooping ideas in ImpactAlpha’s newsroom (audio)

ImpactAlpha, April 14 – Don’t refer to conventional finance as ‘mainstream,’ ImpactAlpha’s David Bank said on The Call earlier this month. Call it ‘legacy finance’ in the same way the tech community refers to ‘legacy’ computer systems that are outdated but still in use. That was one takeaway from The Call No. 10, which took ImpactAlpha

Global Health Investment Fund clears a profit on voucher sale to Novo Nordisk

An innovative financing mechanism for drugs for neglected diseases is providing a return for impact investors. Novo Nordisk, the Danish pharmaceutical giant, disclosed that it is the buyer of a “priority review voucher” from Medicines Development for Global Health, an Australian nonprofit that won U.S. Food and Drug Administration approval for moxidectin as a treatment